Virginia Retirement Systems’s Allogene Therapeutics ALLO Stock Holding History

Virginia Retirement Systems’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$403K	Buy	127,000 +1,800	+1%	+$7.89K	﹤0.01%	755
2023 Q2	$622K	Buy	125,200 +22,700	+22%	+$123K	0.01%	668
2023 Q1	$506K	Buy	102,500 +55,800	+119%	+$358K	0.01%	740
2022 Q4	$294K	Buy	46,700 +24,800	+113%	+$230K	﹤0.01%	970
2022 Q3	$237K	Buy	+21,900	New	+$298K	﹤0.01%	1017
2022 Q1	$113K	Buy	+12,400	New	+$129K	﹤0.01%	1087
2021 Q4	–	Sell	-9,700	Closed	-$249K	–	1101
2021 Q3	$249K	Sell	9,700 -100	-1%	-$2.37K	﹤0.01%	914
2021 Q2	$256K	Buy	+9,800	New	+$279K	﹤0.01%	950

Other funds holding ALLO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virginia Retirement Systems's ALLO Position: Q3 2023 in Review

Virginia Retirement Systems increased its Allogene Therapeutics (ALLO) stake by 1.4% in Q3 2023, buying an estimated $7.89K and bringing the position to 127,000 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Virginia Retirement Systems first reported a position in ALLO in Q2 2021 and has held it in 8 quarters since. The position peaked at $622K in Q2 2023. 154 funds tracked by Wall St. Rank hold ALLO as of Q3 2023.

Virginia Retirement Systems held 127,000 shares of Allogene Therapeutics worth $403K as of Q3 2023.
Virginia Retirement Systems bought 1,800 Allogene Therapeutics shares in Q3 2023, an estimated $7.89K.
Allogene Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #755 holding.
Virginia Retirement Systems first reported a position in Allogene Therapeutics in Q2 2021 and has held it in 8 quarters since.
Virginia Retirement Systems's Allogene Therapeutics position peaked at $622K in Q2 2023.
154 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.